Dimitrios Chondros

SVP, Chief Medical Officer, Halozyme Therapeutics.

Companies

Halozyme TherapeuticsSVP, Chief Medical Officer May 7, 2018 to Aug 5, 2019¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHalozyme Therapeutics, SVP, Chief Medical Officer